chlamydia: be active in males

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents infection
Weight: 0.54
, organism
Weight: 0.33
Siblings syphilis
Weight: 0.35
, gonorrhea
Weight: 0.35
, lyme disease
Weight: 0.34
, genital herpes
Weight: 0.34

Related properties

Property Similarity
be active in males 1.00
affect males 0.87
affect females 0.83
be higher in females 0.82
be diagnosed in males 0.81
be such threat to females 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.05
Rule weight: 0.13
Evidence weight: 0.47
Similarity weight: 0.87
Evidence: 0.70
¬ Remarkable(chlamydia, be active in males)
Evidence: 0.76
¬ Remarkable(gonorrhea, affect males)

Remarkability from sibling implausibility

0.50
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.87
Evidence: 0.67
Plausible(chlamydia, be active in males)
Evidence: 0.76
Remarkable(gonorrhea, affect males)
Evidence: 0.60
¬ Plausible(gonorrhea, affect males)

Salient implies Plausible

0.21
Rule weight: 0.28
Evidence weight: 0.74
Similarity weight: 1.00
Evidence: 0.67
Plausible(chlamydia, be active in males)
Evidence: 0.77
¬ Salient(chlamydia, be active in males)

Similarity expansion

0.68
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.83
Evidence: 0.67
Typical(chlamydia, be active in males)
Evidence: 0.13
¬ Typical(chlamydia, affect females)
0.63
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.83
Evidence: 0.67
Plausible(chlamydia, be active in males)
Evidence: 0.35
¬ Plausible(chlamydia, affect females)
0.61
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.82
Evidence: 0.67
Typical(chlamydia, be active in males)
Evidence: 0.39
¬ Typical(chlamydia, be higher in females)
0.61
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.87
Evidence: 0.77
Salient(chlamydia, be active in males)
Evidence: 0.77
¬ Salient(chlamydia, affect males)
0.61
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.83
Evidence: 0.77
Salient(chlamydia, be active in males)
Evidence: 0.62
¬ Salient(chlamydia, affect females)
0.61
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.87
Evidence: 0.67
Typical(chlamydia, be active in males)
Evidence: 0.54
¬ Typical(chlamydia, affect males)
0.60
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.82
Evidence: 0.77
Salient(chlamydia, be active in males)
Evidence: 0.61
¬ Salient(chlamydia, be higher in females)
0.59
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.87
Evidence: 0.67
Plausible(chlamydia, be active in males)
Evidence: 0.60
¬ Plausible(chlamydia, affect males)
0.59
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.82
Evidence: 0.67
Plausible(chlamydia, be active in males)
Evidence: 0.47
¬ Plausible(chlamydia, be higher in females)
0.59
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.81
Evidence: 0.70
Remarkable(chlamydia, be active in males)
Evidence: 0.47
¬ Remarkable(chlamydia, be diagnosed in males)
0.58
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.81
Evidence: 0.77
Salient(chlamydia, be active in males)
Evidence: 0.68
¬ Salient(chlamydia, be diagnosed in males)
0.56
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.87
Evidence: 0.70
Remarkable(chlamydia, be active in males)
Evidence: 0.80
¬ Remarkable(chlamydia, affect males)
0.54
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.81
Evidence: 0.67
Plausible(chlamydia, be active in males)
Evidence: 0.67
¬ Plausible(chlamydia, be diagnosed in males)
0.54
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.82
Evidence: 0.70
Remarkable(chlamydia, be active in males)
Evidence: 0.79
¬ Remarkable(chlamydia, be higher in females)
0.53
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.76
Evidence: 0.77
Salient(chlamydia, be active in males)
Evidence: 0.82
¬ Salient(chlamydia, be such threat to females)
0.52
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.76
Evidence: 0.67
Typical(chlamydia, be active in males)
Evidence: 0.60
¬ Typical(chlamydia, be such threat to females)
0.52
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.81
Evidence: 0.67
Typical(chlamydia, be active in males)
Evidence: 0.77
¬ Typical(chlamydia, be diagnosed in males)
0.51
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.76
Evidence: 0.67
Plausible(chlamydia, be active in males)
Evidence: 0.66
¬ Plausible(chlamydia, be such threat to females)
0.51
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.83
Evidence: 0.70
Remarkable(chlamydia, be active in males)
Evidence: 0.94
¬ Remarkable(chlamydia, affect females)
0.49
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.76
Evidence: 0.70
Remarkable(chlamydia, be active in males)
Evidence: 0.81
¬ Remarkable(chlamydia, be such threat to females)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.89
Similarity weight: 1.00
Evidence: 0.77
Salient(chlamydia, be active in males)
Evidence: 0.67
¬ Typical(chlamydia, be active in males)
Evidence: 0.70
¬ Remarkable(chlamydia, be active in males)

Typical implies Plausible

0.37
Rule weight: 0.48
Evidence weight: 0.78
Similarity weight: 1.00
Evidence: 0.67
Plausible(chlamydia, be active in males)
Evidence: 0.67
¬ Typical(chlamydia, be active in males)

Typicality and Rermarkability incompatibility between siblings

0.07
Rule weight: 0.14
Evidence weight: 0.60
Similarity weight: 0.87
Evidence: 0.70
¬ Remarkable(chlamydia, be active in males)
Evidence: 0.57
¬ Typical(gonorrhea, affect males)